The Dublin-based AMBER (Advanced Materials + BioEngineering Research) centre is creating 3D-bioprinted implants for osteoarthritis patients as part of a $4.9m project with Johnson & Johnson. Advanced Materials + BioEngineering Research aims to develop a hybrid implant with a titanium core, that can be seeded with patient tissue to encourage regeneration instead of just replacing the diseased joint. The implants could address problems faced by about 900,000 people in Ireland and about 28.9% of the UK population.
The Dublin-based Advanced Materials + BioEngineering Research (AMBER) centre is creating 3D-bioprinted implants for osteoarthritis patients as part of a $4.9m project with Johnson & Johnson. AMBER aims to develop a hybrid implant with a titanium core, that can be seeded with patient tissue to encourage regeneration instead of just replacing the diseased joint. The implants could address problems faced by about 900,000 people in Ireland and about 28.9% of the UK population.